The Therapy Center of Excellence is dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy (TRT) as an alternative to other treatments. The Therapy Center is creating a multi-disciplinary interest group to share ideas, develop education offerings and advance the utilization of radionuclide therapy.
The Therapy Center of Excellence is an organizational component within the SNMMI dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy as an alternative to other treatments. Specifically, the new center will bring together a centralized group of all constituents within this area creating a multi-disciplinary interest group whereby industry, big pharma, physicians, scientists, government and regulatory agencies as well as other stakeholders can convene to share ideas, develop education offerings and advance the utilization of radionuclide therapy.
The Therapy Center of Excellence:
(a) Provides a forum for members with similar interests
(b) Provides expertise in TRT
(c) Fosters research and education in TRT
(d) Provides outreach to other professionals and organizations
(e) Nurtures new membership in SNMMI
Overview of Proposed Center of Excellence Activities
The center will focus on several initiatives, specific to the SNMMI Strategic Plan Goal C: Increase Appropriate Utilization of Radionuclide Therapy within the first year:
Objective 1: Assist in the Development of Emerging Agents.
Objective 2: Advocacy for Regulatory Approval and Reimbursement of Emerging Agents.
Objective 3: Advanced the Use of Approved Agents.
|Neeta Pandit-Taskar, MD|
The Saul Hertz, MD Award
SNMMI has established The Dr. Saul Hertz Lifetime Achievement Award in honor of the professional achievements of Dr. Hertz as the pioneer of Radioiodine Therapy. The award recognizes individuals who have made outstanding contributions to radionuclide therapy.
Therapy Center of Excellence Young Investigator Awards
The Therapy Center of Excellence is pleased to offer the Young Investigator Awards (YIAs) which are supported by grants from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF).
SNMMI 2022 Annual Meeting
June 11-14, 2022 | Vancouver, BC, Canada
We are excited to welcome you back to an in-person SNMMI Annual Meeting—widely recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. Make your plans now to attend SNMMI's flagship meeting, June 11-14 in Vancouver, BC, Canada.
While we encourage you to attend in-person for the complete meeting experience, in-person and virtual registration options are available. Both options give you access to live-streamed sessions to watch virtually from your hotel room or other convenient location, and on-demand sessions for 30 days. Choose the "complete meeting package" to add access to meeting recordings for three years in the SNMMI Learning Center.
2022 SNMMI Annual Meeting Education Sessions
Saturday, June 11; 7:30 am – 3:00 pm
CAT03: Radiopharmaceutical Therapies - Current and Upcoming Theranostic Agents (co-sponsor with AAC)
Sunday, June 12, 2022; 3:00 – 4:30 pm
CE18: Next Generation Targets in Radiopharmaceutical Therapy
Monday, June 13, 2022; 4:00 – 5:30 pm
CE37: Alphas and Betas of PSMA Radioligand Therapy (Joint Session with WARMTH)
Tuesday, June 14, 2022; 10:00 – 11:30 am
CE47: Nuts and Bolts - Radioligand Therapy
Tuesday, June 14, 2022; 1:00 – 2:30 pm
CE54: Saul Hertz Award Lecture
Tuesday, June 14, 2022; 3:00 – 4:30 pm
CE56: Thyroid Cancer Management
Membership dues is $15 annually.
Member benefits include:
- Eligibility to vote in the Therapy COE Board of Directors elections
- Sponsored educational symposia related to members’ interests
- Therapy CoE E-Community
- A $20.00 discount for Therapy CoE sponsored categorical session
Join The Therapy Center of Excellence
- or -
Forward your request in writing with your check for annual center dues ($15) to SNMMI Membership Services, 1850 Samuel Morse Drive, Reston, VA 20190-5316. If you have any further questions about the Therapy Center of Excellence membership, please contact MemberInfo@snmmi.org
SNMMI designated Centers of Excellence in Radiopharmaceutical Therapy meet strict regulatory, training, qualification, experience, and performance criteria to help assure patients, their families, referring physicians, and payors that rigorous procedures are in place and followed, leading to appropriate patient selection and outcomes from radiopharmaceutical therapy.
Learn more about designating your therapy site as a Center of Excellence.